--- schema_version: "secwatch.filing_event.v1" accession: "0001104659-26-073015" form_type: "8-K" ticker: "OCGN" cik: "0001372299" company_name: "Ocugen, Inc." filed_at: "2026-06-11T21:19:26+00:00" generated_at: "2026-06-11T21:20:18.527330+00:00" event_type: "leadership" sentiment: "neutral" materiality_score: 0.5 calibrated_materiality_score: 0.5 confidence: "high" source: SEC EDGAR --- # Ocugen appoints Mohamed Genead as permanent Chief Medical Officer; shareholders elect directors and approve say-on-pay ## Summary - Mohamed Genead, M.D., M.Sc., appointed Chief Medical Officer effective June 11, 2026; had served as Acting/Interim CMO since May 8, 2026. - Shareholders elected Kirsten Castillo and Satish Chandran as Class III directors for terms expiring in 2029. - Say-on-pay advisory vote approved: 49,968,948 votes for, 13,245,090 against, 1,505,123 abstentions. - Shareholders preferred a one-year frequency for future say-on-pay votes; Board adopted that frequency. - Ratification of PwC as independent auditor for fiscal 2026 passed with 136,784,245 votes for. ## SEC filing metadata - accession: 0001104659-26-073015 - form_type: 8-K - ticker: OCGN - cik: 0001372299 - company_name: Ocugen, Inc. - filed_at: 2026-06-11T21:19:26+00:00 - event_type: leadership - sentiment: neutral - materiality_score: 0.5 - calibrated_materiality_score: 0.5 - confidence: high - sec_items: 5.07, 8.01 - EDGAR index: https://www.sec.gov/Archives/edgar/data/1372299/000110465926073015/0001104659-26-073015-index.htm - EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1372299/000110465926073015/tm2617722d1_8k.htm ## Machine-readable alternates - HTML: https://secwatch.observer/filing/0001104659-26-073015 - JSON: https://secwatch.observer/filing/0001104659-26-073015.json - Plain text: https://secwatch.observer/filing/0001104659-26-073015.txt ## Key facts - Shareholder Votes Ocugen, Inc. shareholders approved Approval, on an advisory basis, of the compensation of the Company’s named executive officers at the 2026-06-11 meeting. - Proposal: say on pay - Outcome: passed - Meeting: 2026-06-11 source text: (c) Proposal 3 - Approval, on an advisory basis, of the compensation of the Company’s named executive officers. The stockholders voted to approve, on an advisory basis, the compensation of the Company’s named executive officers, as follows: Votes For Votes Against Abstentions Broker Non-Votes 49,968,948 13,245,090 1,505,123 74,908,914 evidence_url: https://www.sec.gov/Archives/edgar/data/1372299/000110465926073015/0001104659-26-073015-index.htm - Shareholder Votes Ocugen, Inc. shareholders approved Election of Two Class III Directors at the 2026-06-11 meeting. - Proposal: director election - Outcome: passed - Meeting: 2026-06-11 source text: On June 11, 2026, Ocugen, Inc. (the "Company") held its 2026 Annual Meeting of Stockholders (the "Annual Meeting") virtually at 8:00 a.m. ET. At the Annual Meeting, a total of 139,628,075 shares of the Common Stock were represented virtually or by proxy. The following is a brief description of the final voting results for each of the proposals submitted to a vote of the stockholders at the Annual Meeting on June 11, 2026: (a) Proposal 1 - Election of Two Class III Directors. The stockholders elected Kirsten Castillo, MBA, and Satish Chandran, Ph.D. to the Board of Directors of the Company (the "Board") to serve as a director until the 2029 Annual Meeting of Stockholders and until their respective successor, if any, is elected and qualified, or until their earlier death, resignation, retirement, disqualification, or other removal, as follows: Name For Withheld Broker Non-Votes Kirsten Castillo, MBA 56,242,944 8,476,217 74,908,914 Satish Chandran, Ph.D. 62,604,983 2,114,178 74,908,914 evidence_url: https://www.sec.gov/Archives/edgar/data/1372299/000110465926073015/0001104659-26-073015-index.htm - Shareholder Votes Ocugen, Inc. shareholders approved Approval, on an advisory basis, of the preferred frequency of future advisory votes on the compensation of the Company’s named executive officers at the 2026-06-11 meeting. - Proposal: say on pay frequency - Outcome: passed - Meeting: 2026-06-11 source text: (d) Proposal 4 - Approval, on an advisory basis, of the preferred frequency of future advisory votes on the compensation of the Company’s named executive officers . The stockholders voted to approve, on an advisory basis, a preferred frequency of “one year” for future advisory votes on the compensation of the Company’s named executive officers, as follows: Votes For 1 Year Votes For 2 Years Votes For 3 Years Abstentions Broker Non-Votes 57,545,540 1,584,772 3,520,522 2,068,327 74,908,914 evidence_url: https://www.sec.gov/Archives/edgar/data/1372299/000110465926073015/0001104659-26-073015-index.htm - Shareholder Votes Ocugen, Inc. shareholders approved Ratification of Independent Registered Public Accountant at the 2026-06-11 meeting. - Proposal: auditor ratification - Outcome: passed - Meeting: 2026-06-11 source text: (b) Proposal 2 - Ratification of Independent Registered Public Accountant . The ratification of the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the 2026 fiscal year, as follows: Votes For Votes Against Abstentions Broker Non-Votes 136,784,245 1,002,550 1,841,280 - evidence_url: https://www.sec.gov/Archives/edgar/data/1372299/000110465926073015/0001104659-26-073015-index.htm This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.